| Mechanisms | Effects on bone |
---|---|---|
AGEs | Osteoclastogenesis and osteoblast dysfunction [28] | Increased risk of fragility fracture [28] |
Insulin and IGF-1 | Increases osteoblast proliferation and promotes collagen synthesis [38] | Negative correlation with hip and vertebral fracture [39] |
PPARγ | Differentiate MSC into adipocytes [42] | Suppression of osteoblastogenesis [43] |
Enteric hormones (incretins) | Low incretin levels decrease bone formation and augment resorption [47,48,49,50] | |
Osteocalcin | Low levels in T2DM [54] | |
Wnt/B-catenin pathway: sclerostin | High levels in T2DM [59] | High sclerostin levels increase bone resorption [59] |
Vitamin D3 | Low levels in T2DM [31] Reduction of 1,25(OH)2D3 receptors [61] | Reduction of osteocalcin synthesis [61] |